| Size | Price | Stock | Qty |
|---|---|---|---|
| 100mg |
|
||
| Other Sizes |
| Targets |
Human Endogenous Metabolite
|
|---|---|
| References | |
| Additional Infomation |
Itaconic acid is a dicarboxylic acid, a derivative of methacrylic acid, in which one methyl hydrogen is replaced by a carboxylic acid group. It is a metabolite of both fungi and humans. It is a dicarboxylic acid, an olefinic compound, and a dicarboxylic acid fatty acid. Its function is related to succinic acid. It is the conjugate acid of itaconic acid (2-). Itaconic acid is a metabolite found or produced in Escherichia coli (K12 strain, MG1655 strain). Itaconic acid has also been reported in potatoes, corn smut, and several other organisms with relevant data.
|
| Molecular Formula |
C5H6O4
|
|---|---|
| Molecular Weight |
130.10
|
| Exact Mass |
130.026
|
| CAS # |
97-65-4
|
| Related CAS # |
Itaconic acid-13C5;2095777-38-9
|
| PubChem CID |
811
|
| Appearance |
White to off-white solid powder
|
| Density |
1.4±0.1 g/cm3
|
| Boiling Point |
381.4±25.0 °C at 760 mmHg
|
| Melting Point |
165-168 °C(lit.)
|
| Flash Point |
198.7±19.7 °C
|
| Vapour Pressure |
0.0±1.9 mmHg at 25°C
|
| Index of Refraction |
1.498
|
| LogP |
0.38
|
| Hydrogen Bond Donor Count |
2
|
| Hydrogen Bond Acceptor Count |
4
|
| Rotatable Bond Count |
3
|
| Heavy Atom Count |
9
|
| Complexity |
158
|
| Defined Atom Stereocenter Count |
0
|
| InChi Key |
LVHBHZANLOWSRM-UHFFFAOYSA-N
|
| InChi Code |
InChI=1S/C5H6O4/c1-3(5(8)9)2-4(6)7/h1-2H2,(H,6,7)(H,8,9)
|
| Chemical Name |
2-methylidenebutanedioic acid
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: Please store this product in a sealed and protected environment, avoid exposure to moisture. |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
H2O :~27.78 mg/mL (~213.53 mM)
|
|---|---|
| Solubility (In Vivo) |
Solubility in Formulation 1: 25 mg/mL (192.16 mM) in PBS (add these co-solvents sequentially from left to right, and one by one), clear solution; with sonication.
(Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 7.6864 mL | 38.4320 mL | 76.8640 mL | |
| 5 mM | 1.5373 mL | 7.6864 mL | 15.3728 mL | |
| 10 mM | 0.7686 mL | 3.8432 mL | 7.6864 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
